Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
CompletedNCT00868699
Lurasidone for depression
This study is completed in the United States, in France, in Czechia, .... It is testing lurasidone for depression.
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateApril 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 505
- Sponsor
- Sumitomo Pharma America, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, France, Czechia, ...
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT00868699
- Official title
- A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00868699. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Czechia · 4 sites
- Medical Services Prague s.r.o.Kolejni 429-5, PragueSite status: Not listed — confirm with the team
- Psychiatricka ambulanceBrno - MestoSite status: Not listed — confirm with the team
- BIALBI s.r.o., Psychiatricke OddeleniLitoměřiceSite status: Not listed — confirm with the team
- Clintrial, s.r.o.PragueSite status: Not listed — confirm with the team
France · 2 sites
- Hopital Caremeau, Service de Psychiatrie ANîmesSite status: Not listed — confirm with the team
- Zans Ritter, MarcelOrvaultSite status: Not listed — confirm with the team
India · 9 sites
- S V Medical CollegeTirupati, Andh PradSite status: Not listed — confirm with the team
- Vijayawada Institute of Mental Health and Neurosciences, PsychiatryVijaywada, Andh PradSite status: Not listed — confirm with the team
- Samvedna HospitalsAhmedabad, GujaratSite status: Not listed — confirm with the team
- Seth K M School of P G Medicine & ResearchAhmedabad, GujaratSite status: Not listed — confirm with the team
- Mental Illness Treatment Rehabilitationi FoundationAhmedabad, GujaratSite status: Not listed — confirm with the team
- Spandana Nursing HomeBangalore, KarnaSite status: Not listed — confirm with the team
- Sujata Birla Hospital & Research CentreNashik, MaharaSite status: Not listed — confirm with the team
- R.K. Yadav Memorial Mental Health & De-Addiction HospitalJaipur, RajasthanSite status: Not listed — confirm with the team
- Manobal Med. Research CentreLucknow, Uttar PradSite status: Not listed — confirm with the team
Romania · 5 sites
- Spitalul Clinic de Urgenta Militar CentralBucdrestiSite status: Not listed — confirm with the team
- Spitalul Clinic de Psihaiatrie Prof. Dr. Alexandru ObregiaBucharestSite status: Not listed — confirm with the team
- Spitalul Clinic Judetean de Urgenta ClujCluj-NapocaSite status: Not listed — confirm with the team
- Spitalul Clinic de Neuropsihiatrie CraiovaCraiovaSite status: Not listed — confirm with the team
- Spitalul Clinic de Neurologie si Psihiatrie OradeaOradeaSite status: Not listed — confirm with the team
Russia · 3 sites
- City Psychiatric Hospital #2 of St. Nikolay ChudotvoretsSaint PetersburgSite status: Not listed — confirm with the team
- Bekhterev Scientific Research Psychoneurological InstituteSaint PetersburgSite status: Not listed — confirm with the team
- Psychoneurology Dispensary #4Saint PetersburgSite status: Not listed — confirm with the team
South Africa · 5 sites
- Cape Trial CentreCape Town, W. CapeSite status: Not listed — confirm with the team
- Paarl Medical CentrePaarl, W. CapeSite status: Not listed — confirm with the team
- ClinikaPort Elizabeth, E. CapeSite status: Not listed — confirm with the team
- Dey ClinicPretoria, GautengSite status: Not listed — confirm with the team
- Vereeniging Medi-ClinicVereeniging, Free StateSite status: Not listed — confirm with the team
Ukraine · 5 sites
- Chair of Psychiatry and Medical PsychologyDonetsk, Donetsk OblastSite status: Not listed — confirm with the team
- Reg. Psychiatric HospitalOdesaSite status: Not listed — confirm with the team
- Reg Cl.Ps.H.n.a.O.F. Malstev, Fem.Ac. Gen. Ps.D.5BPoltavaSite status: Not listed — confirm with the team
- CRI Cl.Psych.Hosp. #1, Fem. Psych. Dept. #2, Male ISimferopolSite status: Not listed — confirm with the team
- Reg. Psych. Hosp.n.a.O.Yuschenko, Dept #21VinnitsiaSite status: Not listed — confirm with the team
United States · 22 sites
- Synergy Escondido,710 East Grand Ave.Escondido, CaliforniaSite status: Not listed — confirm with the team
- Collaborative Neuroscience Network Inc.,12772 Valley View Street,Suite 3Garden Grove, CaliforniaSite status: Not listed — confirm with the team
- Excell Research, Inc,3998 Vista Way,Suite 100Oceanside, CaliforniaSite status: Not listed — confirm with the team
- University of California at Irvine Medical CenterOrange, CaliforniaSite status: Not listed — confirm with the team
- California Neuropsychopharmacology,CNRI - Los Angeles LLC,8309 Telegraph RoadPico Rivera, CaliforniaSite status: Not listed — confirm with the team
- California Neuropsychopharmacology Clinical Research Institute, LLC,466 26th Street,6th FloorSan Diego, CaliforniaSite status: Not listed — confirm with the team
- University of ColoradoAurora, ColoradoSite status: Not listed — confirm with the team
- Florida Clinical Research Center, LLC,3914 State Road 64 EastBradenton, FloridaSite status: Not listed — confirm with the team
- Florida Clinical Research Center, LLC,2300 Maitland Center Parkway,Suite 230Maitland, FloridaSite status: Not listed — confirm with the team
- Depression and Anxiety Disorders Research InstituteTampa, FloridaSite status: Not listed — confirm with the team
- Janus Center for Psychiatric Research,5601 Corporate Way,Suite 103West Palm Beach, FloridaSite status: Not listed — confirm with the team
- American Medical Research Inc.,1200 Harger Road Suite 415Oak Brook, IllinoisSite status: Not listed — confirm with the team
- Lake Charles Clinical Trials LLC,2770 3rd Avenue,Suite 340Lake Charles, LouisianaSite status: Not listed — confirm with the team
- Sheppard Pratt Health System,6501 North Charles StreetBaltimore, MarylandSite status: Not listed — confirm with the team
- Albuquerque Neuroscience Inc., 101 Hospital Loop, NE, Suite 209Albuquerque, New MexicoSite status: Not listed — confirm with the team
- Neurobehavioral Research, Inc.Cedarhurst, New YorkSite status: Not listed — confirm with the team
- Finger Lakes Clinical ResearchRochester, New YorkSite status: Not listed — confirm with the team
- Richard H. Weisler., M.D., P.A., & Associates,700 Spring Forest Road,Suite 125Raleigh, North CarolinaSite status: Not listed — confirm with the team
- Mood Disorders Program-UHCMCCleveland, OhioSite status: Not listed — confirm with the team
- MetroHealth SystemCleveland, OhioSite status: Not listed — confirm with the team
- CRI Worldwide, LLCPhiladelphia, PennsylvaniaSite status: Not listed — confirm with the team
- FutureSearch Clinical Trials, LLC.,4200 Marathon Blvd.,Suite 200Austin, TexasSite status: Not listed — confirm with the team
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving lurasidone, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with bipolarity; age range: From 18 Years to 75 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Sumitomo Pharma America, Inc., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT06717724
§ Procaine Periarticular Injections for Pain Reduction in Elderly With Osteoarthritis
This study is completed. It focuses on depression and currently lists study information in Romania.
CompletedNCT00223496
12- Week Open Label Treatment of Refractory Depression in bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
CompletedNCT02363738
12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
This study is completed. It focuses on bipolarity and currently lists study information in Canada and the United States.